Stock comparison
BIOGEN INC. is 2.9x more valuable than BIO-TECHNE Corp by market capitalization ($32.60 B vs $11.34 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BIIB is larger
BIOGEN INC. is 2.9x more valuable than BIO-TECHNE Corp by market capitalization ($32.60 B vs $11.34 B).
Market value leader
BIIB
BIOGEN INC. is 2.9x more valuable than BIO-TECHNE Corp by market capitalization ($32.60 B vs $11.34 B).
Revenue leader
BIIB
TECH: $1.22B vs BIIB: $9.89B.
Profit leader
BIIB
TECH: $73.40M vs BIIB: $1.29B.
Margin leader
BIIB
TECH: 6.0% vs BIIB: 13.1% net margin.
| Metric | TECH | BIIB |
|---|---|---|
| Market cap | $11.34 B | $32.60 B |
| US-listed rank | #882 | #448 |
| Revenue (latest FY) | $1.22B | $9.89B |
| Net income (latest FY) | $73.40M | $1.29B |
| Net margin | 6.0% | 13.1% |
| P/E (trailing FY) | 154.5x | 25.2x |
| SEC filings | 1,229 | 2,692 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BIOGEN INC. is 2.9x more valuable than BIO-TECHNE Corp by market capitalization ($32.60 B vs $11.34 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while BIOGEN INC. reported $9.89B.
Full pages: BIO-TECHNE Corp and BIOGEN INC., or browse the full rankings.